Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company AnaCardio has been granted patent for its drug candidate AC01 as an inotropic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback